Seaport Res Ptn Comments on Aspen Aerogels, Inc.’s Q1 2025 Earnings (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN) – Investment analysts at Seaport Res Ptn reduced their Q1 2025 earnings per share (EPS) estimates for Aspen Aerogels in a report released on Thursday, October 10th. Seaport Res Ptn analyst T. Curran now anticipates that the construction company will earn $0.04 per share for the quarter, down from their previous forecast of $0.11. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.21 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.10 EPS, Q3 2025 earnings at $0.14 EPS and Q4 2025 earnings at $0.14 EPS.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million during the quarter, compared to analysts’ expectations of $101.99 million. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. Aspen Aerogels’s revenue for the quarter was up 144.4% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.22) earnings per share.

ASPN has been the subject of several other reports. B. Riley raised Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. Barclays initiated coverage on Aspen Aerogels in a report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 target price on the stock. TD Cowen upped their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Finally, Roth Mkm reiterated a “buy” rating and set a $36.00 target price on shares of Aspen Aerogels in a report on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.70.

Aspen Aerogels Stock Down 1.5 %

ASPN stock opened at $22.76 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The stock has a market capitalization of $1.73 billion, a P/E ratio of -51.73 and a beta of 2.16. The business has a 50-day moving average of $25.79 and a 200-day moving average of $24.29. Aspen Aerogels has a fifty-two week low of $6.62 and a fifty-two week high of $33.15.

Institutional Investors Weigh In On Aspen Aerogels

A number of large investors have recently modified their holdings of ASPN. Driehaus Capital Management LLC lifted its stake in shares of Aspen Aerogels by 130.4% in the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after acquiring an additional 1,220,724 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares during the last quarter. Millennium Management LLC bought a new position in shares of Aspen Aerogels in the 2nd quarter valued at $9,339,000. Hood River Capital Management LLC lifted its stake in shares of Aspen Aerogels by 12.2% in the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after acquiring an additional 357,895 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of Aspen Aerogels in the 2nd quarter valued at $8,340,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.